Effect of dopaminergic medication on speech dysfluency in Parkinson’s disease: a longitudinal study

Journal of Neural Transmission

Volumn 122, Issue 8, 2015, Pages 1135-1142

  Tykalová, Tereza ^a   Rusz, Jan ^a,b   Čmejla, Roman ^a   Klempíř, Jiří ^b   Růžičková, Hana ^b   Roth, Jan ^b   Růžička, Evžen ^b  

^a CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acquired stuttering; Developmental stuttering; Dopamine; Dysfluency; Levodopa; Parkinson s disease

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CZECH (CITIZEN); DRUG INDUCED DISEASE; FEMALE; FLUENCY DISORDER; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; READING; SPEECH ANALYSIS; STUTTERING; UNIFIED PARKINSON DISEASE RATING SCALE; COMPLICATION; DRUG EFFECTS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SPEECH; SPEECH DISORDERS;

ADULT; AGED; DOPAMINE AGENTS; FEMALE; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SPEECH; SPEECH ACOUSTICS; SPEECH DISORDERS;

EID: 84938826826     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-015-1363-y     Document Type: Article

References (33)

1. Ackermann H, Ziegler W, Oertel WH (1989) Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 52:805–807
2. Akaike A, Ohno Y, Sasa M, Takaori S (1987) Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res 418:262–272
3. Alm PA (2004) Stuttering and the basal ganglia circuits: a critical review of possible relations. J Commun Disord 37:325–369
4. Anderson JM, Hughes JD, Rothi LJG, Crucian GP, Heilman KM (1999) Developmental stuttering and Parkinson’s disease: the effects of levodopa treatment. J Neurol Neurosur Ps 66:776–778
5. Benke TH, Hohenstein C, Poewe W, Butterworth B (2000) Repetitive speech phenomena in Parkinson’s disease. J Neurol Neurosur Ps 69:319–325
6. Brady JP (1991) The pharmacology of stuttering: a critical review. Am J Psychiatry 148:1309–1316
7. Burghaus L, Hilker R, Thiel A, Galldiks N, Lehnhardt FG et al (2006) Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson’s disease. J Neural Transm 113:625–631
8. Civier O, Bullock D, Max L, Guenther FH (2013) Computational modeling of stuttering caused by impairments in a basal ganglia thalamo-cortical circuit involved in syllable selection and initiation. Brain Lang 196:263–278
9. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. New Engl J Med 355:896–908
10. Giraud AL, Neumann K, Bachoud-Levi AC, von Gudenberg AW, Euler HA et al (2008) Severity of dysfluency correlates with basal ganglia activity in persistent developmental stuttering. Brain Lang 104:190–199
11. Goberman AM, Blomgren M (2003) Parkinsonian speech disfluencies: effects of l-dopa-related fluctuations. J Fluency Disord 28:55–77
12. Goberman AM, Blomgren M, Metzger E (2010) Characteristics of speech disfluency in Parkinson disease. J Neurolinguist 23:470–478
13. Ho AK, Bradshaw JL, Iansek R (2008) For better or worse: the effect of levodopa on speech in Parkinson’s disease. Mov Disord 23:575–580
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
15. Jellinger KA (2012) Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord 27:8–30
16. Kim H, Hasegawa-Johnson M, Perlman A (2011) Vowel contrast and speech intelligibility in dysarthria. Folia Phoniatr Logop 63:187–194
17. Koller WC (1983) Dysfluency (stuttering) in extrapyramidal disease. Arch Neurol 40:175–177
18. Leder SB (1996) Adult onset of stuttering as a presenting sign in a parkinsonian-like syndrome: a case report. J Commun Disord 29:471–478
19. Logemann JA, Fisher HB, Boshes B, Blonsky ER (1978) Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Res 43:47–57
20. Louis ED, Winfield L, Fahn S, Ford B (2001) Speech dysfluency exacerbated by levodopa in Parkinson’s disease. Mov Disord 16:562–581
21. Maguire GA, Yu BP, Franklin DL, Riley GD (2004) Alleviating stuttering with pharmacological interventions. Expert Opin Pharmaco 5:1565–1571
22. Nebel A, Reese R, Deuschl G, Mehdorn HM, Volkmann J (2009) Acquired stuttering after pallidal brain stimulation for dystonia. J Neural Transm 116:167–169
23. Rusz J, Cmejla R, Ruzickova H, Ruzicka E (2011) Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am 129:350–367
24. Rusz J, Cmejla R, Tykalova T, Ruzickova H, Klempir J et al (2013) Imprecise vowel articulation as a potential early marker of Parkinson’s disease: effect of speaking task. J Acoust Soc Am 134:2171–2181
25. Sapir S, Spielman JL, Ramig LO, Story BH, Fox C (2007) Effects of Intensive Voice Treatment (the Lee Silverman Voice Treatment [LSVT]) on Vowel Articulation in Dysarthric Individuals With Idiopathic Parkinson Disease: acoustic and Perceptual Findings. J Speech Lang Hear R 50:899–913
26. Sapir S, Ramig LO, Fox C (2008) Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 16:205–210
27. Shahed J, Jankovic J (2001) Re-emergence of childhood stuttering in Parkinson’s disease: a hypothesis. Mov Disord 16:114–118
28. Skodda S, Gronheit W, Schlegel U (2012) Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS ONE 7:e32132
29. Teesson K, Packman A, Onslow M (2003) The Lidcombe behavioral data language of stuttering. J Speech Lang Hear R 46:1009–1015
30. Thiriez C, Roubeau B, Ouerchefani N, Gurruchaga JM, Palfi S et al (2013) Improvement in developmental stuttering following deep brain stimulation for Parkinson’s disease. Parkinsonism Relat D 19:383–384
31. Watkins KE, Smith SM, Davis S, Howell P (2008) Structural and functional abnormalities of the motor system in developmental stuttering. Brain 131:50–59
32. Williams GV, Castner SA (2006) Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 139:263–276
33. Wu JC, Maguire G, Riley G, Lee A, Keator D et al (1997) Increased dopamine activity associated with stuttering. NeuroReport 8:767–770